MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension

In this review, the potential future role of microRNA-based therapies and their specific application in lung diseases is reported with special attention to pulmonary hypertension. Current limitations of these therapies will be pointed out in order to address the challenges that they need to face to...

Full description

Bibliographic Details
Main Authors: Susana Carregal-Romero, Lucía Fadón, Edurne Berra, Jesús Ruíz-Cabello
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/9/3253
_version_ 1797568842495426560
author Susana Carregal-Romero
Lucía Fadón
Edurne Berra
Jesús Ruíz-Cabello
author_facet Susana Carregal-Romero
Lucía Fadón
Edurne Berra
Jesús Ruíz-Cabello
author_sort Susana Carregal-Romero
collection DOAJ
description In this review, the potential future role of microRNA-based therapies and their specific application in lung diseases is reported with special attention to pulmonary hypertension. Current limitations of these therapies will be pointed out in order to address the challenges that they need to face to reach clinical applications. In this context, the encapsulation of microRNA-based therapies in nanovectors has shown improvements as compared to chemically modified microRNAs toward enhanced stability, efficacy, reduced side effects, and local administration. All these concepts will contextualize in this review the recent achievements and expectations reported for the treatment of pulmonary hypertension.
first_indexed 2024-03-10T20:02:50Z
format Article
id doaj.art-da0c04dc5b4340f19a6c2d7fc2c8bfe0
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T20:02:50Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-da0c04dc5b4340f19a6c2d7fc2c8bfe02023-11-19T23:27:52ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-05-01219325310.3390/ijms21093253MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary HypertensionSusana Carregal-Romero0Lucía Fadón1Edurne Berra2Jesús Ruíz-Cabello3Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 182, 20014 San Sebastián, SpainCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 182, 20014 San Sebastián, SpainCenter for Cooperative Research in Bioscience (CIC bioGUNE), Buiding 800, Science and Technology Park of Bizkaia, 48160 Derio, SpainCenter for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón 182, 20014 San Sebastián, SpainIn this review, the potential future role of microRNA-based therapies and their specific application in lung diseases is reported with special attention to pulmonary hypertension. Current limitations of these therapies will be pointed out in order to address the challenges that they need to face to reach clinical applications. In this context, the encapsulation of microRNA-based therapies in nanovectors has shown improvements as compared to chemically modified microRNAs toward enhanced stability, efficacy, reduced side effects, and local administration. All these concepts will contextualize in this review the recent achievements and expectations reported for the treatment of pulmonary hypertension.https://www.mdpi.com/1422-0067/21/9/3253non-coding RNAmicroRNAreplacement therapyantisense-mediated inhibitionmimicRNAlung targeting
spellingShingle Susana Carregal-Romero
Lucía Fadón
Edurne Berra
Jesús Ruíz-Cabello
MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
International Journal of Molecular Sciences
non-coding RNA
microRNA
replacement therapy
antisense-mediated inhibition
mimicRNA
lung targeting
title MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
title_full MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
title_fullStr MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
title_full_unstemmed MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
title_short MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
title_sort microrna nanotherapeutics for lung targeting insights into pulmonary hypertension
topic non-coding RNA
microRNA
replacement therapy
antisense-mediated inhibition
mimicRNA
lung targeting
url https://www.mdpi.com/1422-0067/21/9/3253
work_keys_str_mv AT susanacarregalromero micrornananotherapeuticsforlungtargetinginsightsintopulmonaryhypertension
AT luciafadon micrornananotherapeuticsforlungtargetinginsightsintopulmonaryhypertension
AT edurneberra micrornananotherapeuticsforlungtargetinginsightsintopulmonaryhypertension
AT jesusruizcabello micrornananotherapeuticsforlungtargetinginsightsintopulmonaryhypertension